학술논문

Treatment With JAK Inhibitors in Myelofibrosis Patients Nullifies the Prognostic Impact of Unfavorable Cytogenetics
Document Type
Article
Source
In: Clinical Lymphoma, Myeloma and Leukemia. (Clinical Lymphoma, Myeloma and Leukemia, May 2018, 18(5):e201-e210)
Subject
Language
English
ISSN
21522669
21522650